Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Left Ventricular Ejection Fraction
100%
Carvedilol
100%
Cardiomyopathy
100%
Trastuzumab
100%
Therapeutic Interventions
100%
Cardiovascular Therapy
80%
Cardiotoxicity
60%
Trastuzumab Therapy
40%
Human Epidermal Growth Factor
40%
Heart Failure
40%
Receptor 2
40%
Epidermal Growth Factor (EGF) Receptor
40%
Clinical Trials
20%
Cardiac Dysfunction
20%
Breast Cancer Patients
20%
Troponin Elevation
20%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
Breast Cancer
20%
Wait-and-see Approach
20%
Vulnerability
20%
Cardiac Troponin
20%
Trastuzumab Cardiotoxicity
20%
Beta-blockers
20%
Global Longitudinal Strain
20%
Care Approach
20%
Cardio
20%
Preventive Approach
20%
Pharmacogenomics
20%
Patient Experience
20%
Breast Cancer Treatment
20%
Cardioprotection
20%
Management Strategies
20%
Pharmacology, Toxicology and Pharmaceutical Science
Carvedilol
100%
Trastuzumab
100%
Myocardial Disease
100%
Cardiotoxicity
80%
Breast Cancer
60%
Gamma Urogastrone
60%
Congestive Heart Failure
40%
Epidermal Growth Factor Receptor
40%
Epidermal Growth Factor Receptor 2
20%
Beta Adrenergic Receptor Blocking Agent
20%
Troponin
20%
Clinical Trial
20%
Side Effect
20%
Pharmacogenomics
20%